Nu-Med Plus (NUMD) Accumulated Depreciation & Amortization (2011 - 2022)

Nu-Med Plus has disclosed Accumulated Depreciation & Amortization across 12 years of filings, most recently posting $2267.0 for Q4 2022.

• Accumulated Depreciation & Amortization for Q4 2022 came in at $2267.0, down 75.79% year-over-year; the trailing twelve-month figure through Dec 2022 was $2267.0 (down 75.79% YoY), and the FY2022 annual result was $2267.0, down 75.79% from the prior year.
• Accumulated Depreciation & Amortization came in at $2267.0 for Q4 2022 at Nu-Med Plus, roughly flat from $2267.0 in the prior quarter.
• In the past five years, Accumulated Depreciation & Amortization ranged from a high of $82802.0 in Q2 2021 to a low of $2015.0 in Q1 2022.
• The 5-year median for Accumulated Depreciation & Amortization is $51690.0 (2018), against an average of $43047.8.
• Across the five-year window, Accumulated Depreciation & Amortization soared 51.08% in 2018 and tumbled 97.52% in 2022, its largest moves.
• Nu-Med Plus' Accumulated Depreciation & Amortization stood at $53577.0 in 2018, then increased by 24.95% to $66943.0 in 2019, then climbed by 17.62% to $78737.0 in 2020, then sank by 88.11% to $9365.0 in 2021, then plunged by 75.79% to $2267.0 in 2022.
• The last three Accumulated Depreciation & Amortization figures came in at $2267.0 (Q4 2022), $2267.0 (Q3 2022), and $2232.0 (Q2 2022), per Business Quant data.